118 related articles for article (PubMed ID: 11948476)
21. Human glutathione S-transferase polymorphisms associated with prostate cancer in the Brazilian population.
Så RA; Moreira Ados S; Cabello PH; Ornellas AA; Costa EB; Matos Cda S; Alves G; Hatagima A
Int Braz J Urol; 2014; 40(4):463-73. PubMed ID: 25251951
[TBL] [Abstract][Full Text] [Related]
22. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier.
Maugard CM; Charrier J; Pitard A; Campion L; Akande O; Pleasants L; Ali-Osman F
Int J Cancer; 2001 Feb; 91(3):334-9. PubMed ID: 11169956
[TBL] [Abstract][Full Text] [Related]
24. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.
Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA
Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399
[TBL] [Abstract][Full Text] [Related]
25. Evaluating polymorphic status of glutathione-S-transferase genes in blood and tissue samples of prostate cancer patients.
Mittal RD; Mishra DK; Mandhani A
Asian Pac J Cancer Prev; 2006; 7(3):444-6. PubMed ID: 17059341
[TBL] [Abstract][Full Text] [Related]
26. Single nucleotide polymorphism of pi-class glutathione s-transferase and susceptibility to endometrial carcinoma.
Chan QK; Khoo US; Ngan HY; Yang CQ; Xue WC; Chan KY; Chiu PM; Ip PP; Cheung AN
Clin Cancer Res; 2005 Apr; 11(8):2981-5. PubMed ID: 15837751
[TBL] [Abstract][Full Text] [Related]
27. Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk.
Kittles RA; Young D; Weinrich S; Hudson J; Argyropoulos G; Ukoli F; Adams-Campbell L; Dunston GM
Hum Genet; 2001 Sep; 109(3):253-61. PubMed ID: 11702204
[TBL] [Abstract][Full Text] [Related]
28. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.
Miller DP; De Vivo I; Neuberg D; Wain JC; Lynch TJ; Su L; Christiani DC
Int J Cancer; 2003 May; 104(6):758-63. PubMed ID: 12640684
[TBL] [Abstract][Full Text] [Related]
29. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
Nam RK; Elhaji Y; Krahn MD; Hakimi J; Ho M; Chu W; Sweet J; Trachtenberg J; Jewett MA; Narod SA
J Urol; 2000 Aug; 164(2):567-72. PubMed ID: 10893645
[TBL] [Abstract][Full Text] [Related]
30. Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells.
Vidanes GM; Paton V; Wallen E; Peehl DM; Navone N; Brooks JD
Prostate; 2002 Jun; 51(4):225-30. PubMed ID: 11987150
[TBL] [Abstract][Full Text] [Related]
31. Androgen receptor CAG polymorphism and prostate cancer risk.
Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
[TBL] [Abstract][Full Text] [Related]
32. Short tandem repeat polymorphism linkage to the androgen receptor gene in prostate carcinoma.
Riley DE; Krieger JN
Cancer; 2001 Nov; 92(10):2603-8. PubMed ID: 11745195
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
[TBL] [Abstract][Full Text] [Related]
34. Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer.
Antognelli C; Mearini L; Talesa VN; Giannantoni A; Mearini E
Prostate; 2005 May; 63(3):240-51. PubMed ID: 15538743
[TBL] [Abstract][Full Text] [Related]
35. Glutathione S-transferase GSTP1 genotypes are associated with response to androgen ablation therapy in advanced prostate cancer.
Luscombe CJ; French ME; Liu S; Saxby MF; Farrell WE; Jones PW; Fryer AA; Strange RC
Cancer Detect Prev; 2002; 26(5):376-80. PubMed ID: 12518868
[TBL] [Abstract][Full Text] [Related]
36. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis.
Ntais C; Polycarpou A; Ioannidis JP
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):176-81. PubMed ID: 15668493
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms of glutathione S-transferase Mu 1, glutathione S-transferase theta 1 and glutathione S-transferase Pi 1 genes in Hodgkin's lymphoma susceptibility and progression.
Lourenço GJ; Néri IA; Sforni VC; Kameo R; Lorand-Metze I; Lima CS
Leuk Lymphoma; 2009 Jun; 50(6):1005-9. PubMed ID: 19391035
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms at GSTM1 and GSTP1 gene loci and risk of prostate cancer in a South Indian population.
Vijayalakshmi K; Vettriselvi V; Krishnan M; Shroff S; Vishwanathan KN; Jayanth VR; Paul SF
Asian Pac J Cancer Prev; 2005; 6(3):309-14. PubMed ID: 16235991
[TBL] [Abstract][Full Text] [Related]
39. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.
Millar DS; Ow KK; Paul CL; Russell PJ; Molloy PL; Clark SJ
Oncogene; 1999 Feb; 18(6):1313-24. PubMed ID: 10022813
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset.
Hardy DO; Scher HI; Bogenreider T; Sabbatini P; Zhang ZF; Nanus DM; Catterall JF
J Clin Endocrinol Metab; 1996 Dec; 81(12):4400-5. PubMed ID: 8954049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
